Literature DB >> 3308665

Lack of hepatic transferrin receptor expression in hemochromatosis.

R Sciot1, A C Paterson, J J Van den Oord, V J Desmet.   

Abstract

The major part of hepatocellular iron is derived from uptake of transferrin-bound iron by means of nonspecific fluid-phase endocytosis and specific, saturable binding on high-affinity transferrin receptors. We investigated the expression of transferrin receptors on hepatocytes in liver biopsies of 22 cases of hemochromatosis (21 primary hemochromatosis and 1 secondary hemochromatosis), using immunohistochemical demonstration of the human transferrin receptor with the specific monoclonal antibody OKT9. Fifty liver biopsies (normal and pathological) without demonstrable iron storage (Perls' stain negative) served as controls. In the controls, membranous and/or cytoplasmic transferrin receptor expression was always present on hepatocytes, albeit in variable numbers and patterns without obvious relation to the underlying liver disease. In 19 of 22 hemochromatosis cases with severe iron overload, OKT9 immunoreactivity on hepatocytes was completely absent. Three hemochromatosis cases showed few hepatocytes positive for OKT9. One showed mild iron overload, while the second, a successfully treated case, was free of iron. The remaining hemochromatosis case was a known alcoholic with severe iron overload. Since OKT9 binding to the transferrin receptor is not blocked by previous binding of transferrin, the findings show that in advanced hemochromatosis hepatocytes do not express transferrin receptors. This finding is in keeping with the inverse relation between transferrin receptor expression and exogenous iron supply in various cell cultures. These results indicate that in hemochromatosis,apparently as a result of progressive iron overload,transferrin receptor expression on hepatocytes disappears.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308665     DOI: 10.1002/hep.1840070507

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

2.  Neonatal hemochromatosis. The regulation of transferrin-receptor and ferritin synthesis by iron in cultured fibroblastic-line cells.

Authors:  A S Knisely; J B Harford; R D Klausner; S R Taylor
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Duodenal iron proteins in idiopathic hemochromatosis.

Authors:  P Whittaker; B S Skikne; A M Covell; C Flowers; A Cooke; S R Lynch; J D Cook
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.

Authors:  R E Fleming; M C Migas; C C Holden; A Waheed; R S Britton; S Tomatsu; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

5.  Optimizing the immunohistochemical signal from the transferrin receptor in liver tissue.

Authors:  M Lombard; N V Naoumov; A Bomford; R Williams; M Hynes; P Dervan; J Crowe
Journal:  Histochem J       Date:  1989-04

6.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

7.  Duodenal absorption and tissue utilization of dietary heme and nonheme iron differ in rats.

Authors:  Chang Cao; Carrie E Thomas; Karl L Insogna; Kimberly O O'Brien
Journal:  J Nutr       Date:  2014-09-10       Impact factor: 4.798

8.  Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.

Authors:  Martha B Johnson; Juxing Chen; Nicholas Murchison; Frank A Green; Caroline A Enns
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

Review 9.  Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.

Authors:  Pallavi Pandey; Ankur Pandey; Mary Dillhoff; Carl Schmidt; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.